Osteoporosis drugs to undergo FDA safety review
The Food and Drug Administration (FDA) is going to be taking another look at Fosamax and other bone building drugs because they could be causing irregular heartbeats in some patients.
Attorney Consultation
Verdict
› $150,000,000 verdict in personal injury case